AHL Partners’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | $3.27M | Sell |
22,123
-30,178
| -58% | -$4.46M | 0.05% | 593 |
|
|
2017
Q3 | $6.13M | Buy |
52,301
+17,515
| +50% | +$2.05M | 0.11% | 332 |
|
|
2017
Q2 | $4.51M | Buy |
34,786
+14,057
| +68% | +$1.82M | 0.1% | 390 |
|
|
2017
Q1 | $2.81M | Buy |
20,729
+7,346
| +55% | +$995K | 0.06% | 533 |
|
|
2016
Q4 | $1.92M | Buy |
13,383
+4,199
| +46% | +$602K | 0.06% | 520 |
|
|
2016
Q3 | $1.08M | Buy |
9,184
+3,363
| +58% | +$397K | 0.04% | 572 |
|
|
2016
Q2 | $617K | Buy |
5,821
+2,482
| +74% | +$263K | 0.03% | 562 |
|
|
2016
Q1 | $372K | Sell |
3,339
-13,101
| -80% | -$1.46M | 0.02% | 627 |
|
|
2015
Q4 | $2.58M | Buy |
16,440
+13,877
| +541% | +$2.17M | 0.2% | 190 |
|
|
2015
Q3 | $336K | Sell |
2,563
-26,928
| -91% | -$3.53M | 0.05% | 527 |
|
|
2015
Q2 | $5.13M | Sell |
29,491
-1,282
| -4% | -$223K | 0.2% | 171 |
|
|
2015
Q1 | $5.31M | Buy |
30,773
+10,787
| +54% | +$1.86M | 0.21% | 153 |
|
|
2014
Q4 | $2.59M | Buy |
+19,986
| New | +$2.59M | 0.13% | 327 |
|